{"count": 11, "results": [{"_id": "21273666", "pmid": 21273666, "title": "Hemostatic effects of simvastatin in subjects with impaired fasting glucose.", "journal": "Pharmacol Rep", "authors": ["Krysiak R", "Gdula-Dymek A", "Okopień B"], "date": "2010-11-01T00:00:00Z", "doi": "10.1016/s1734-1140(10)70371-6", "meta_date_publication": "2010 Nov-Dec", "meta_volume": "62", "meta_issue": "6", "meta_pages": "1090-8", "score": 50081.207, "text_hl": "Hemostatic effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in subjects with @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@.", "citations": {"NLM": "Krysiak R, Gdula-Dymek A, Okopień B. Hemostatic effects of simvastatin in subjects with impaired fasting glucose. Pharmacol Rep. 2010 Nov-Dec;62(6):1090-8. PMID: 21273666", "BibTeX": "@article{21273666, title={Hemostatic effects of simvastatin in subjects with impaired fasting glucose.}, author={Krysiak R and Gdula-Dymek A and Okopień B}, journal={Pharmacol Rep}, volume={62}, number={6}, pages={1090-8}}"}}, {"_id": "21108528", "pmid": 21108528, "title": "The effect of simvastatin on lymphocyte secretory function in patients with impaired fasting glucose.", "journal": "J Cardiovasc Pharmacol", "authors": ["Krysiak R", "Okopien B"], "date": "2010-11-01T00:00:00Z", "doi": "10.1097/fjc.0b013e3181f301e0", "meta_date_publication": "2010 Nov", "meta_volume": "56", "meta_issue": "5", "meta_pages": "491-7", "score": 50073.598, "text_hl": "The effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on lymphocyte secretory function in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@.", "citations": {"NLM": "Krysiak R, Okopien B. The effect of simvastatin on lymphocyte secretory function in patients with impaired fasting glucose. J Cardiovasc Pharmacol. 2010 Nov;56(5):491-7. PMID: 21108528", "BibTeX": "@article{21108528, title={The effect of simvastatin on lymphocyte secretory function in patients with impaired fasting glucose.}, author={Krysiak R and Okopien B}, journal={J Cardiovasc Pharmacol}, volume={56}, number={5}, pages={491-7}}"}}, {"_id": "10546006", "pmid": 10546006, "title": "Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.", "journal": "Diabetes Care", "authors": ["Herman WH", "Alexander CM", "Cook JR", "Boccuzzi SJ", "Musliner TA", "Pedersen TR", "Kjekshus J", "Pyörälä K"], "date": "1999-11-01T00:00:00Z", "doi": "10.2337/diacare.22.11.1771", "meta_date_publication": "1999 Nov", "meta_volume": "22", "meta_issue": "11", "meta_pages": "1771-8", "score": 50073.137, "text_hl": "Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment on cardiovascular resource utilization in @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Herman WH, Alexander CM, Cook JR, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, Pyörälä K. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care. 1999 Nov;22(11):1771-8. PMID: 10546006", "BibTeX": "@article{10546006, title={Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.}, author={Herman WH and Alexander CM and Cook JR and Boccuzzi SJ and Musliner TA and Pedersen TR and Kjekshus J and Pyörälä K}, journal={Diabetes Care}, volume={22}, number={11}, pages={1771-8}}"}}, {"_id": "22716204", "pmid": 22716204, "title": "Haemostatic effects of metformin in simvastatin-treated volunteers with impaired fasting glucose.", "journal": "Basic Clin Pharmacol Toxicol", "authors": ["Krysiak R", "Okopien B"], "date": "2012-12-01T00:00:00Z", "doi": "10.1111/j.1742-7843.2012.00913.x", "meta_date_publication": "2012 Dec", "meta_volume": "111", "meta_issue": "6", "meta_pages": "380-4", "score": 50071.387, "text_hl": "Haemostatic effects of @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-treated volunteers with @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@.", "citations": {"NLM": "Krysiak R, Okopien B. Haemostatic effects of metformin in simvastatin-treated volunteers with impaired fasting glucose. Basic Clin Pharmacol Toxicol. 2012 Dec;111(6):380-4. PMID: 22716204", "BibTeX": "@article{22716204, title={Haemostatic effects of metformin in simvastatin-treated volunteers with impaired fasting glucose.}, author={Krysiak R and Okopien B}, journal={Basic Clin Pharmacol Toxicol}, volume={111}, number={6}, pages={380-4}}"}}, {"_id": "20955358", "pmid": 20955358, "title": "Anti-inflammatory and monocyte-suppressing effects of simvastatin in patients with impaired fasting glucose.", "journal": "Basic Clin Pharmacol Toxicol", "authors": ["Krysiak R", "Gdula-Dymek A", "Scieszka J", "Okopień B"], "date": "2011-02-01T00:00:00Z", "doi": "10.1111/j.1742-7843.2010.00633.x", "meta_date_publication": "2011 Feb", "meta_volume": "108", "meta_issue": "2", "meta_pages": "131-7", "score": 50067.668, "text_hl": "Anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ and monocyte-suppressing effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@.", "citations": {"NLM": "Krysiak R, Gdula-Dymek A, Scieszka J, Okopień B. Anti-inflammatory and monocyte-suppressing effects of simvastatin in patients with impaired fasting glucose. Basic Clin Pharmacol Toxicol. 2011 Feb;108(2):131-7. PMID: 20955358", "BibTeX": "@article{20955358, title={Anti-inflammatory and monocyte-suppressing effects of simvastatin in patients with impaired fasting glucose.}, author={Krysiak R and Gdula-Dymek A and Scieszka J and Okopień B}, journal={Basic Clin Pharmacol Toxicol}, volume={108}, number={2}, pages={131-7}}"}}, {"_id": "22841520", "pmid": 22841520, "title": "The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose.", "journal": "Metabolism", "authors": ["Krysiak R", "Okopien B"], "date": "2013-01-01T00:00:00Z", "doi": "10.1016/j.metabol.2012.06.009", "meta_date_publication": "2013 Jan", "meta_volume": "62", "meta_issue": "1", "meta_pages": "39-43", "score": 50065.48, "text_hl": "The effect of @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ on monocyte secretory function in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-treated @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@.", "citations": {"NLM": "Krysiak R, Okopien B. The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose. Metabolism. 2013 Jan;62(1):39-43. PMID: 22841520", "BibTeX": "@article{22841520, title={The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose.}, author={Krysiak R and Okopien B}, journal={Metabolism}, volume={62}, number={1}, pages={39-43}}"}}, {"_id": "29165724", "pmid": 29165724, "title": "Protective Effect and Potential Mechanism of Simvastatin on Myocardial Injury Induced by Diabetes with Hypoglycemia.", "journal": "Exp Clin Endocrinol Diabetes", "authors": ["Li H", "Zhao Q", "Liu R", "Yang L", "Chen H", "Cui X"], "date": "2018-03-01T00:00:00Z", "doi": "10.1055/s-0043-110481", "meta_date_publication": "2018 Mar", "meta_volume": "126", "meta_issue": "3", "meta_pages": "148-161", "score": 50065.21, "text_hl": "The cardiac protective effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment (at a dose of 40 mg/kg d) upon @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@diabetic hypoglycemia@@@ models was assessed. ", "citations": {"NLM": "Li H, Zhao Q, Liu R, Yang L, Chen H, Cui X. Protective Effect and Potential Mechanism of Simvastatin on Myocardial Injury Induced by Diabetes with Hypoglycemia. Exp Clin Endocrinol Diabetes. 2018 Mar;126(3):148-161. PMID: 29165724", "BibTeX": "@article{29165724, title={Protective Effect and Potential Mechanism of Simvastatin on Myocardial Injury Induced by Diabetes with Hypoglycemia.}, author={Li H and Zhao Q and Liu R and Yang L and Chen H and Cui X}, journal={Exp Clin Endocrinol Diabetes}, volume={126}, number={3}, pages={148-161}}"}}, {"_id": "10597756", "pmid": 10597756, "title": "Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.", "journal": "Arch Intern Med", "authors": ["Haffner SM", "Alexander CM", "Cook TJ", "Boccuzzi SJ", "Musliner TA", "Pedersen TR", "Kjekshus J", "Pyörälä K"], "date": "1999-12-13T00:00:00Z", "doi": "10.1001/archinte.159.22.2661", "meta_date_publication": "1999 Dec 13-27", "meta_volume": "159", "meta_issue": "22", "meta_pages": "2661-7", "score": 50064.0, "text_hl": "Reduced coronary events in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-treated @SPECIES_9606 @@@patients@@@ with @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ or @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@ levels: subgroup analyses in the Scandinavian @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Survival Study.", "citations": {"NLM": "Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, Pyörälä K. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med. 1999 Dec 13-27;159(22):2661-7. PMID: 10597756", "BibTeX": "@article{10597756, title={Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.}, author={Haffner SM and Alexander CM and Cook TJ and Boccuzzi SJ and Musliner TA and Pedersen TR and Kjekshus J and Pyörälä K}, journal={Arch Intern Med}, volume={159}, number={22}, pages={2661-7}}"}}, {"_id": "23107042", "pmid": 23107042, "title": "Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose.", "journal": "Atherosclerosis", "authors": ["Krysiak R", "Okopien B"], "date": "2012-12-01T00:00:00Z", "doi": "10.1016/j.atherosclerosis.2012.09.034", "meta_date_publication": "2012 Dec", "meta_volume": "225", "meta_issue": "2", "meta_pages": "403-7", "score": 50055.62, "text_hl": "METHODS: Sixty-two subjects with @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@ (@<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@IFG@@@) treated for at least 3 months with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ were allocated into one of two groups receiving, respectively, @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ (3 g daily) or placebo for the following 90 days. ", "citations": {"NLM": "Krysiak R, Okopien B. Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose. Atherosclerosis. 2012 Dec;225(2):403-7. PMID: 23107042", "BibTeX": "@article{23107042, title={Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose.}, author={Krysiak R and Okopien B}, journal={Atherosclerosis}, volume={225}, number={2}, pages={403-7}}"}}, {"_id": "22935083", "pmid": 22935083, "title": "The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances.", "journal": "Basic Clin Pharmacol Toxicol", "authors": ["Krysiak R", "Gdula-Dymek A", "Okopien B"], "date": "2013-03-01T00:00:00Z", "doi": "10.1111/bcpt.12003", "meta_date_publication": "2013 Mar", "meta_volume": "112", "meta_issue": "3", "meta_pages": "198-202", "score": 50049.883, "text_hl": "The study included 47 @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerotic@@@ @SPECIES_9606 @@@patients@@@ with the concomitant presence of @<m>DISEASE_Hypoglycemia</m> @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@ and @DISEASE_Glucose_Intolerance @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@ already receiving @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment (40 mg daily) who were allocated to one of two groups treated for 90 days with, respectively, @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ (200 mg daily) or placebo. ", "citations": {"NLM": "Krysiak R, Gdula-Dymek A, Okopien B. The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. Basic Clin Pharmacol Toxicol. 2013 Mar;112(3):198-202. PMID: 22935083", "BibTeX": "@article{22935083, title={The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances.}, author={Krysiak R and Gdula-Dymek A and Okopien B}, journal={Basic Clin Pharmacol Toxicol}, volume={112}, number={3}, pages={198-202}}"}}]}